NIH Opens RM1 Broad Funding Path for Interdisciplinary Team Science
NIH has issued a new RM1 Broad Funding Opportunity to back scientific problems that cannot be answered by a single laboratory or a loose collaboration. The award is built for projects in which multiple investigators bring different expertise to one integrated question, with each contributor functioning as part of a coordinated research unit rather than as an independent subcontracted partner.
The distinction matters because some biomedical problems resist the usual grant structure. Complex mechanisms, multiscale datasets, and translational questions often demand a team that can move in lockstep across disciplines, whether the work involves biology, computation, engineering, or clinical insight. The new Collaborative Program Grant for Interdisciplinary Teams is designed to support that model through several NIH Institutes, Centers, and Offices working together under a broad funding announcement.
A single sentence captures the premise: some questions are too interdependent for siloed science.
A Grant Structure Built Around Integration, Not Parallel Work
The NIH announcement is aimed at projects where success depends on genuine scientific interdependence. In practical terms, that means the research is not simply a collection of separate aims bundled into one application. Instead, the team must operate as a system, with expertise distributed across members in a way that each component changes the scientific direction of the others.
That structure reflects how many modern biomedical challenges are actually solved. Gene regulation, host-pathogen interactions, immune signaling, disease modeling, and large-scale data interpretation often require simultaneous progress in multiple domains. One investigator may define the biological question, another may develop the analytic framework, and a third may supply experimental or translational expertise that keeps the entire project anchored in clinical relevance.
For applicants, the new funding path creates a home for proposals that might otherwise feel too ambitious for a conventional mechanism. It also signals that NIH is willing to support science whose value lies in the quality of coordination as much as the strength of any single component.
Why Team Science Needs a Dedicated Mechanism
Biomedical research increasingly depends on specialized expertise that no individual group can fully hold in-house. A mechanistic question about disease progression may require molecular assays, imaging, advanced statistics, and domain-specific clinical interpretation. A public health intervention may need behavioral science, implementation research, health economics, and rigorous measurement of outcomes. When those elements are merely adjacent, progress slows. When they are interdependent, the project can be much more powerful.
The RM1 framework acknowledges that reality by favoring integrated projects whose scientific logic depends on collaboration from the outset. That can improve rigor, because the proposal has to show how the team will function as a coordinated unit rather than an assembly of independent specialists. It can also improve feasibility, since the funding structure is built for work that would be difficult to manage through narrower mechanisms.
There is also a cultural effect. Grant systems shape what gets studied. When a funding mechanism exists for interdependent team science, investigators are more likely to design projects that cross disciplinary borders instead of forcing a complex problem into a smaller, less suitable mold.
What the NIH Announcement Signals for Investigators
The broad announcement was issued with multiple NIH Institutes, Centers, and Offices involved, which gives the opportunity unusual reach across the biomedical research portfolio. That kind of coordination matters because the most difficult scientific problems rarely sit inside one mission area. Disease mechanisms, prevention strategies, and translational tools often span basic, clinical, and population-level research.
Applicants considering the mechanism will need to think differently about project design. The strongest submissions will likely be those in which the team structure is not decorative but essential to the science. A project that can be divided into isolated work packages will not fully fit the spirit of the RM1 model. A project that depends on real-time exchange between disciplines, by contrast, aligns with the purpose of the award.
The policy message is straightforward. NIH wants to make room for scientific questions that need a collaborative architecture from day one.
Wider Implications for Biomedical Research Strategy
This funding opportunity also fits into a broader effort to make NIH mechanisms easier to navigate and better aligned with how science is actually done. Instead of asking investigators to bend ambitious ideas into outdated grant forms, the agency is carving out a clearer route for highly integrated research teams.
For early-stage and established investigators alike, the new option may encourage more thoughtful planning around collaboration. The most competitive projects will probably be those that show not just multidisciplinary membership, but a compelling reason the science collapses without that structure. In other words, the award is not meant to simply gather experts in one room; it is meant to support work in which the research question itself demands a shared engine.
That is a useful signal for the field. As biomedical questions become more complex, the funding system is adjusting to reward projects that can turn diversity of expertise into a scientific advantage. The remaining challenge is not whether teams can be assembled. It is whether those teams can be built with enough integration, rigor, and scientific necessity to justify the mechanism.
The next test will be how investigators use the opportunity and whether the projects supported under RM1 deliver the kind of coordinated science the award was built to enable.